Subungual Melanoma represents a multisystem concern requiring integrated treatment approaches.
Overview
First-line therapies for Subungual Melanoma have established efficacy and favorable safety profiles.
- Hutchinson's sign: Extension of pigmentation onto the nail fold (highly suggestive of malignancy)
- Pigmented nail band: Longitudinal brown or black band extending from the proximal to distal nail
- Band irregularity: Asymmetric borders and variable pigmentation within the band
- Band width: Greater than 3 mm suggests malignancy
- Loss of nail transparency: Darkening of the nail plate
- Nail destruction: Onycholysis or nail plate deformity in advanced cases
Clinical Features and Presentation
Patients with Subungual Melanoma present with diverse clinical phenotypes ranging from mild to severe.
Differential Diagnosis
Recognition of pathognomonic features enables accurate and timely diagnosis of Subungual Melanoma.
Diagnostic Approach
Recognition of pathognomonic features enables accurate and timely diagnosis of Subungual Melanoma.
Treatment
Modern management of Subungual Melanoma offers multiple therapeutic options with complementary mechanisms.
Prognosis and Follow-up
With modern therapeutic options, Subungual Melanoma can be effectively controlled in the majority of patients.
Prevention and Patient Education
Lifestyle modifications can significantly reduce Subungual Melanoma flare frequency and severity.
Conclusion
First-line therapies for Subungual Melanoma have established efficacy and favorable safety profiles.
Conclusion
Comprehensive management of Subungual Melanoma integrates clinical expertise with patient education and shared decision-making. Early intervention prevents complications and optimizes long-term outcomes. Dermatologists can provide personalized treatment plans tailored to individual disease manifestations.